Dalurzo, Mercedes L; Salas, Alejandro Avilés; Soares, Fernando Augusto 
; Hou, Yingyong; Li, Yuan; Stroganova, Anna; Öz, Büge; Abdillah, Arif; Wan, Hui; Choi, Yoon-La
Fonte: OncoTargets and Therapy. Unidade: FO
Assuntos: IMUNOHISTOQUÍMICA, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DALURZO, Mercedes L et al. Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: considerations for Countries in Emerging Markets. OncoTargets and Therapy, v. 14, p. Se 2021, 2021Tradução . . Disponível em: https://doi.org/10.2147/OTT.S313669. Acesso em: 03 nov. 2024.APA
Dalurzo, M. L., Salas, A. A., Soares, F. A., Hou, Y., Li, Y., Stroganova, A., et al. (2021). Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: considerations for Countries in Emerging Markets. OncoTargets and Therapy, 14, Se 2021. doi:10.2147/OTT.S313669NLM
Dalurzo ML, Salas AA, Soares FA, Hou Y, Li Y, Stroganova A, Öz B, Abdillah A, Wan H, Choi Y-L. Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: considerations for Countries in Emerging Markets [Internet]. OncoTargets and Therapy. 2021 ; 14 Se 2021.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2147/OTT.S313669Vancouver
Dalurzo ML, Salas AA, Soares FA, Hou Y, Li Y, Stroganova A, Öz B, Abdillah A, Wan H, Choi Y-L. Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: considerations for Countries in Emerging Markets [Internet]. OncoTargets and Therapy. 2021 ; 14 Se 2021.[citado 2024 nov. 03 ] Available from: https://doi.org/10.2147/OTT.S313669
